The Biocidal Products Regulation (BPR, Regulation (EU) 528/2012) establishes the rules for placing biocidal products on the EU market. These products are used to protect people, animals, materials, or articles from harmful organisms - such as bacteria, insects, or fungi - by means of the active substances they contain. 

The BPR aims to harmonise the principles for the evaluation of biocidal products and to improve the efficiency of authorisation procedures while ensuring a high level of protection for human health and the environment. Under the BPR, active substances must first receive approval, before a biocidal product authorisation can be applied for.  Only authorised products can be placed on the market. 

Understanding regulatory challenges under the BPR

For companies developing or marketing biocidal products, navigating evolving regulatory requirements can be complex. Compliance involves multiple processes, detailed documentation, and ongoing communication with regulatory authorities at both national and EU level. 

ARCHE Consulting offers in-depth support for companies involved in the biocides sector, providing regulatory expertise, scientific evaluations, dossier development, and strategic advice aligned with the latest guidance from ECHA and other competent authorities. 

Services and areas of support

Regulatory and strategic advice

To support decision-making and risk management, ARCHE Consulting offers the following services: 

  • Continuous monitoring of regulatory developments 

  • Detailed support and follow-up for EU and GB regulations both under transitional law and BPR 

  • Substance analysis (e.g. hazard profiling for active substances, evaluation of potential endocrine disrupting (ED) properties, screening for Substances of Concern) 

  • Preliminary risk assessments to evaluate claim feasibility 

  • Development of compliance-oriented marketing strategies 

  • Proactive portfolio management to anticipate regulatory impacts

  • Consortium management

Scientific and technical expertise

ARCHE Consulting’s multidisciplinary team includes over 40 specialists with expertise in: 

  • Toxicology (including ED assessments) 

  • Ecotoxicology and environmental fate 

  • Physico-chemical properties

  • Hazard classification 

  • Risk assessment (human health, environmental, dietary, livestock) 

  • Efficacy assessment 

  • CLP classification (Regulation (EC) No 1272/2008) 

  • Consortium and project management 

  • Support for various authorisation procedures (national, Union, Mutual Recognition, Same Biocidal Product) 

  • ...

General dossier preparation and submission

End-to-end regulatory dossier support includes: 

  • Data gap analysis 

  • Study monitoring and coordination with CROs 

  • Preparation of expert opinions and development of waiving justifications 

  • Compilation of regulatory formats: IUCLID, draft CAR, SPC, PAR, etc. 

  • Submission of dossiers and ongoing liaison with regulatory authorities 

  • Pre- and post-submission meetings with ECHA and national agencies 

Active substance specific support

ARCHE Consulting assists with all aspects of active substance approval and management, including: 

  • New active substances (including in situ generated and Annex I substances) 

  • Renewal of active substances 

  • Article 95 compliance 

  • Technical Equivalence assessments 

  • ED assessments (mammalian and non-target species) 

Biocidal Product (Family) specific support

Comprehensive services are provided for the preparation, submission, and management of biocidal product authorisations, including: 

  • Portfolio planning and management 

  • Single biocidal product applications

  • Applications for Biocidal Product Families (including BPF assessments) 

  • Applications for simplified authorisation 

  • Comparative assessments 

National transitional procedures under Article 89 of the BPR
  • Extensive experience and thorough understanding of country-specific requirements and guidance

    • Expert regulatory support tailored to the unique requirements of the Benelux region (Belgium, the Netherlands, Luxembourg), Germany, France, and the Iberian Peninsula (Spain and Portugal).

    • Network of local partners who are knowledgeable about the requirements in other EU countries.

  • High-quality, customised support to help companies successfully register their products and remain compliant with national regulations. 

  • Smooth and efficient registration process.

Training

Tailored training modules are available to support internal teams, covering topics such as: 

  • Introduction to BPR 

  • IUCLID usage and dossier compilation 

  • Risk assessment methodology and practice 

ARCHE Consulting offers a full range of services - from tailored strategic advice and  dossier development to staff training modules. Get in touch for a competitive offer tailored to your company’s needs. 

Contact our experts:

Lieve Claeys

Lieve Claeys

Regulatory Affairs Manager
European Registered Toxicologist

lieve.claeys@arche-consulting.be
+32 9 216 70 67

More about Lieve
An Vanden Bosch, PhD

An Vanden Bosch

Regulatory Affairs Manager
European Registered Toxicologist
IBERA Diplomate

an.vandenbosch@arche-consulting.be
+32 16 28 49 03

More about An